1,516 articles
Hisao Ogawa
Hisao Ogawa (小川 久雄, born 1953) is a Japanese cardiologist who became the 14th president of Kumamoto University in 2021, after leading the National Cerebral and Cardiovascular Center.
Hitinder S. Gurm
Hitinder S. Gurm is an interventional cardiologist at the University of Michigan who directs the statewide BMC2 quality collaborative and serves as interim Chief Medical Officer of Michigan Medicine.
Hölger Thiele
Holger Thiele (born 1969) is a German cardiologist who directs cardiology at the Heart Center Leipzig and is known for the cardiogenic shock trials ECLS-SHOCK, TOMAHAWK, and CULPRIT-SHOCK.
Howard A. Eder
Howard A. Eder was an American physician-scientist at Albert Einstein College of Medicine known for showing in 1951 that HDL is higher in premenopausal women.
Howard B. Sprague
Howard B. Sprague (1895–1970) was an American cardiologist at Massachusetts General Hospital and Harvard Medical School teacher, known for applying phonocardiography to the study of auscultation.
Howard C. Herrmann
Howard C. Herrmann is an American interventional cardiologist and John W. Bryfogle Professor Emeritus at the University of Pennsylvania, a leading investigator in transcatheter aortic valve replacement.
Howard D. Kolodny
Howard D. Kolodny is an American endocrinologist in Great Neck, New York, who trained at NYU and Mount Sinai and published 1971 studies of chlorpromazine as a growth hormone suppressor.
Howard E. Morgan
Howard E. Morgan (1927–2009) was an American cardiac physiologist who studied heart metabolism and workload-driven growth, chaired Physiology at Penn State, and led the American Heart Association.
Howard F. Root
Howard F. Root (1890–1967) was an American physician and diabetes researcher at Harvard and the New England Deaconess Hospital in Boston who gave New England's first insulin injection in 1922.
Howard N. Hodis
Howard N. Hodis is a physician-scientist at the University of Southern California's Keck School of Medicine who directs its Atherosclerosis Research Unit and studies atherosclerosis prevention.
Howard Rasmussen
Howard K. Rasmussen (1925–2005) was an American physician-scientist in endocrinology and calcium metabolism who argued that calcium ion acts as an intracellular messenger alongside cyclic AMP.
Howard S. Tager
Howard S. Tager was an American biochemist at the University of Chicago who reported the first diabetes caused by a structurally abnormal insulin, insulin Chicago.
Hugh Calkins
Hugh Calkins is an American cardiac electrophysiologist who directs electrophysiology at Johns Hopkins, led the 2017 RE-CIRCUIT trial, and is a past President of the Heart Rhythm Society.
Hugh Watkins (British physician-scientist)
Hugh Watkins is a British physician-scientist at the University of Oxford who established that mutations in the heart's motor proteins cause hypertrophic cardiomyopathy, and who leads CureHeart.
Hugo A. Katus
Hugo A. Katus, born 1951, is a German cardiologist who invented the cardiac troponin T blood test and led cardiology at Heidelberg University Hospital from 2002 to 2020.
Hui-Young Lee
Hui-Young Lee is a South Korean scientist who studies insulin resistance, mitochondrial function, and diabetes, and co-authored the 2014 Nature paper on how metformin works.
Hunter Heath
Hunter Heath is an American endocrinologist known for research on calcitonin and primary hyperparathyroidism, who trained at Walter Reed, worked at Mayo Clinic, and later joined Indiana University.
Hyo‐Soo Kim
Hyo-Soo Kim (김효수) is a South Korean cardiologist, professor of internal medicine at Seoul National University, known for large randomised trials of antiplatelet therapy after coronary stenting and cardiovascular stem cell research.
I.L. Chaikoff
Israel Lyon Chaikoff (1902–1966) was a Canadian-born physiologist and biochemist, professor of physiology at UC Berkeley, who pioneered radioactive-isotope tracers and the Wolff–Chaikoff effect, the thyroid's temporary shutdown when iodide rises.
Ian Ford (biostatistician)
Ian Ford is a biostatistician at the University of Glasgow who designed and analyzed landmark clinical trials, including the WOSCOPS statin trial and the PIVOTAL iron trial.
Igor F. Palacios
Igor F. Palacios is a Venezuelan-born interventional cardiologist who led interventional cardiology at Massachusetts General Hospital and performed the first mitral balloon valvuloplasty in the United States.
Iichiro Shimomura
Iichiro Shimomura (下村 伊一郎) is a Japanese physician-scientist, professor of endocrinology and metabolism at The University of Osaka since 2004, whose department discovered the hormone adiponectin and helped establish the metabolic syndrome concept.
Ildiko Lingvay
Ildiko Lingvay is a Romanian-born endocrinologist and professor at UT Southwestern Medical Center in Dallas, known for arguing that weight loss, not glucose control alone, should be the primary goal in type 2 diabetes.
INDER J. CHOPRA
Inder J. Chopra (Inder Jit Chopra) is an endocrinologist, diabetes, and metabolism specialist at UCLA known for developing radioimmunoassays for thyroid hormones and their metabolites.
Inder S. Anand
Inder S. Anand, also published as Inder Anand, is an Indian-born cardiologist who directed the heart failure program at the Minneapolis VA Medical Center and described adult subacute mountain sickness.
Inge Edler
Inge Edler was a Swedish cardiologist who, with the physicist Hellmuth Hertz, recorded the first moving ultrasound echoes from the human heart in Lund, Sweden, in 1953, founding echocardiography.
Ingrid Fleming
Ingrid Fleming is a biochemist and vascular pharmacologist who directs the Institute for Vascular Signalling at Goethe University Frankfurt, studying endothelial cell signaling in diabetes.
Ira D. Goldfine
Ira D. Goldfine is an American physician-scientist at the University of California, San Francisco, known for showing that insulin binds to sites inside cells, including the nucleus.
Ira J. Goldberg
Ira J. Goldberg is an American physician-scientist who leads endocrinology at NYU Langone, having earlier been a Columbia professor, and is known for arguing that cardiovascular disease in diabetes is driven by factors beyond glucose.
Ira Tabas
Ira Tabas, born 1953, is an American physician-scientist at Columbia University known for research on macrophage cell biology in atherosclerosis and, more recently, fatty liver disease in obesity.